Search

everythinglearnresearchcommunity

for

Search:↓

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Finasteride works best in 6 months and lasts 6 years.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

A woman lost her hair from stress after a bee attack and her sister's death.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Acne lesions start with changes in hair follicles and increase in inflammation, suggesting a cycle that could affect treatment strategies.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Laser treatment effectively increases hair density and thickness in androgenic alopecia.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

Combining letrozole with metformin is the most effective treatment for inducing pregnancy in women with PCOS.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.